| scholarly article | Q13442814 |
| P50 | author | Jaakko Tuomilehto | Q28050079 |
| Stefan Söderberg | Q41096685 | ||
| P2093 | author name string | Qing Qiao | |
| Feng Ning | |||
| Altan Onat | |||
| DECODE Study Group | |||
| Kalevi Pyörälä | |||
| P2860 | cites work | The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years | Q30577414 |
| Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies | Q30980456 | ||
| Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria | Q31931889 | ||
| Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. | Q51495723 | ||
| Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. | Q51556661 | ||
| Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. | Q51621447 | ||
| Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. | Q53248709 | ||
| 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee | Q74586325 | ||
| Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group | Q77052861 | ||
| Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe | Q78191116 | ||
| Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects | Q34616729 | ||
| Why does diabetes mellitus increase the risk of cardiovascular disease? | Q36396621 | ||
| Hyperglycemia and stroke mortality: comparison between fasting and 2-h glucose criteria | Q37067159 | ||
| Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose | Q40639755 | ||
| Diabetes and cardiovascular disease. The Framingham study | Q41509493 | ||
| Impaired fasting glucose, blood pressure and cardiovascular disease mortality | Q44167916 | ||
| Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts | Q44262723 | ||
| Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? | Q44333469 | ||
| Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial | Q44459441 | ||
| Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin | Q44777896 | ||
| beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis | Q45105931 | ||
| Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels. | Q46075634 | ||
| Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. | Q46171495 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported | Q19125045 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 2211-2216 | |
| P577 | publication date | 2010-04-27 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range | |
| P478 | volume | 33 |
| Q51286008 | Assessment of Subclinical Atherosclerosis by Carotid Intima-Media Thickness and Epicardial Adipose Tissue Thickness in Prediabetes. |
| Q40048880 | Association of glycated hemoglobin with carotid intimal medial thickness in Asian Indians with normal glucose tolerance |
| Q48502875 | Cardiovascular Risk Factors in Patients with Poorly Controlled Diabetes Mellitus. |
| Q36720353 | Cardiovascular characteristics in subjects with increasing levels of abnormal glucose regulation: the Strong Heart Study |
| Q33628611 | Correlation between mean platelet volume and blood glucose levels after oral glucose loading in normoglycemic and prediabetic Japanese subjects |
| Q36175793 | Development of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range |
| Q40106324 | Different combinations of glucose tolerance and blood pressure status and incident cardiovascular disease and all-cause mortality events |
| Q28728387 | Does insulin resistance drive the association between hyperglycemia and cardiovascular risk? |
| Q22241786 | ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary |
| Q39184189 | Fasting glycemia and glycated hemoglobin categories: Relationship to serum lipoprotein(a) level and disparity in 2 geographic regional groups of Turkey |
| Q51355788 | Fasting plasma glucose correlates with angiographic coronary artery disease prevalence and severity in Chinese patients without known diabetes. |
| Q37504078 | Fitness, fatness, and survival in adults with prediabetes |
| Q35684670 | Glycemic Profiles of Healthy Individuals with Low Fasting Plasma Glucose and HbA1c |
| Q43889455 | Haemoglobin A1c is associated with carotid intima-media thickness in a Chinese population |
| Q38307071 | High normal post-load plasma glucose, cardiometabolic risk factors and signs of organ damage in obese children |
| Q96302866 | Human postprandial responses to food and potential for precision nutrition |
| Q26862823 | Impact of postprandial glycaemia on health and prevention of disease |
| Q38838756 | Increased kallistatin levels in patients with obesity and prediabetes compared to normal glucose tolerance. |
| Q51702089 | Increased peroxiredoxin 4 levels in patients with prediabetes compared to normal glucose tolerance subjects. |
| Q44848861 | Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey |
| Q92650104 | Insulin Resistance in Patients With Acromegaly |
| Q36409060 | Insulin Secretory Defect and Insulin Resistance in Isolated Impaired Fasting Glucose and Isolated Impaired Glucose Tolerance. |
| Q37900473 | Neuropathy in prediabetes: does the clock start ticking early? |
| Q34171676 | Obesity paradoxes |
| Q35260937 | Optimal candidates for the switch from glimepiride to sitagliptin to reduce hypoglycemia in patients with type 2 diabetes mellitus. |
| Q51370555 | Oral glucose tolerance test and HbA₁c for diagnosis of diabetes in patients undergoing coronary angiography: [corrected] the Silent Diabetes Study. |
| Q26767224 | Potential Anti-Atherosclerotic Properties of Astaxanthin |
| Q38257985 | Prediabetes and associated disorders |
| Q59330214 | Reducing Glycemic Indicators with Moderate Intensity Stepping of Varied, Short Durations in People with Pre-Diabetes |
| Q34523674 | Relationship and factors responsible for regulating fasting and post-challenge plasma glucose levels in the early stage development of type 2 diabetes mellitus. |
| Q41516001 | Risk Factors Of Heart Disease in Nurses. |
| Q40060835 | Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China |
| Q40963983 | Risk stratification using the CHA2DS2-VASc score in patients with coronary heart disease undergoing percutaneous coronary intervention; sub-analysis of SHINANO registry. |
| Q49159819 | Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology |
| Q51382645 | Should the metabolic syndrome patient with prediabetes be offered pharmacotherapy? |
| Q37067319 | Slow-release carbohydrates: growing evidence on metabolic responses and public health interest. Summary of the symposium held at the 12th European Nutrition Conference (FENS 2015). |
| Q55023885 | The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study. |
| Q41076426 | The impact of type 2 diabetes mellitus on prognosis in patients with non-ST elevation myocardial infarction. |
| Q38563239 | Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review |
| Q37825945 | Therapies for diabetic dyslipidaemia |
| Q48139457 | Time to redefine body mass index categories in chronic diseases? Spotlight on obesity paradox |
| Q34024327 | Translating "Nondiabetic" A1C levels to clinical practice: the art of medicine |
| Q45276592 | Two-hour post-load plasma glucose levels are associated with carotid intima-media thickness in subjects with normal glucose tolerance |
| Q38213328 | Type-2 diabetes and coronary heart disease: common physiopathology, viewed from autoimmunity |
Search more.